rs78508365
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152468.5(TMC8):c.1350-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000873 in 1,613,790 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_152468.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC8 | NM_152468.5 | c.1350-8C>T | splice_region_variant, intron_variant | ENST00000318430.10 | NP_689681.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC8 | ENST00000318430.10 | c.1350-8C>T | splice_region_variant, intron_variant | 1 | NM_152468.5 | ENSP00000325561.4 |
Frequencies
GnomAD3 genomes AF: 0.00477 AC: 726AN: 152182Hom.: 9 Cov.: 33
GnomAD3 exomes AF: 0.00119 AC: 298AN: 250114Hom.: 2 AF XY: 0.000871 AC XY: 118AN XY: 135522
GnomAD4 exome AF: 0.000469 AC: 685AN: 1461490Hom.: 5 Cov.: 33 AF XY: 0.000420 AC XY: 305AN XY: 727032
GnomAD4 genome AF: 0.00475 AC: 724AN: 152300Hom.: 9 Cov.: 33 AF XY: 0.00446 AC XY: 332AN XY: 74462
ClinVar
Submissions by phenotype
TMC8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Epidermodysplasia verruciformis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at